FDA Inspection 1025293 — Quintiles IMS Ireland Limited

Quintiles IMS Ireland Limited — FEI 3004213842

The FDA completed an inspection of Quintiles IMS Ireland Limited on Sep 15, 2017 in Dublin 3. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 15, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dublin 3 (Ireland)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol
755521 CFR 312.53(d)Selecting monitors

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.